title: Diffuse large B-cell lymphoma presenting as pancoast tumor.
authors.affiliation: Department of Medicine, Roswell Park Cancer Institute, University of Buffalo, NY, USA.
authors.forename: Nuttapong
authors.initials: N
authors.lastname: Ngamphaiboon
authors.forename: Sulada
authors.initials: S
authors.lastname: Pukiat
authors.forename: Yugandhar
authors.initials: Y
authors.lastname: Kandimalla
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Hernandez-Ilizaliturri
authors.forename: James J
authors.initials: JJ
authors.lastname: Rooney
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols; D001707:Biopsy, Needle; D003520:Cyclophosphamide; D003937:Diagnosis, Differential; D004317:Doxorubicin; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008198:Lymph Nodes / Q000473:pathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis* / Q000628:therapy*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008875:Middle Aged; D010178:Pancoast Syndrome / Q000175:diagnosis*; D049268:Positron-Emission Tomography / Q000379:methods; D011239:Prednisolone; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment; D000069283:Rituximab; D012720:Severity of Illness Index; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome; D014750:Vincristine
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone